Professional Documents
Culture Documents
North America dominates the global market for antipsychotics due to the presence of a large number of
aging population, and increasing prevalence of neurological disorders in the region. The market for
antipsychotics in Europe is expected to experience a high growth rate in the next few years. The region
would be followed by Asia. China and India are likely to be the fastest growing markets for antipsychotics
in Asia. Key factors driving the antipsychotics market in emerging countries include presence of a large
pool of patients, and rise in government funding.
Factors such as aging population, increasing prevalence of neurological disorders, and growing
awareness regarding different neurological disorders and their available treatment are driving the global
antipsychotics market. Furthermore, improvement in healthcare facilities and technological advancements
in the field of neurology are also boosting the antipsychotics market. However, factors such as sideeffects associated with antipsychotics and lower adoption rate of antipsychotics have been hampering
market growth.
Growth in demographics and developing economies such as India and China is projected to offer ample
opportunities to the global antipsychotics market. Innovation in some of the existing products, leading to
improvement in the efficiency of antipsychotics is anticipated to offer opportunities for the market. Rising
number of mergers and acquisitions, new product launches, and increasing number of collaborations and
partnerships are some of the latest trends in the global antipsychotics market. Furthermore, the number of
patent expirations in the global antipsychotics market is increasing. Profit margins of companies are likely
to be affected due to the expiry of patents. Side-effects associated with antipsychotics act as a challenge
for the antipsychotics market. Commonly marketed antipsychotics include aripiprazole, asenapine
maleate, clozapine, iloperidone, lurasidone, and olanzapine. Other commonly marketed antipsychotics
include olanzapine/fluoxetine, paliperidone, quetiapine, risperidone, and ziprasidone. Major companies
dealing in global antipsychotics market include Eli Lilly and Company, Pfizer, Inc., and GlaxoSmithKline
Plc. Other companies with significant presence in the antipsychotics market include AstraZeneca Plc,
Bristol-Myers Squibb, and Johnson & Johnson.
Key points covered in the report:1. Report segments the market on the basis of types, application, products, technology, etc
(as applicable)
2. The report covers geographic segmentation
North America
Europe
Asia
RoW
3. The report provides the market size and forecast for the different segments and
geographies for the period of 2010 to 2020
4. The report provides company profiles of some of the leading companies operating in the
market
5. The report also provides porters five forces analysis of the market.
Browse the full All Upcoming Persistence Market's report at
http://www.persistencemarketresearch.com/forthcoming-reports.asp
About Us:
Persistence Market Research is a global market research firm specializing- syndicated
research, custom research, and consulting services